Literature DB >> 30069838

Cholesteatoma Pearls: Practical Points and Update.

James T Castle1.   

Abstract

The European Academy of Otology and Neurotology in collaboration with the Japanese Otological Society (EAONO/JOS) recently produced a joint consensus document outlining the definitions, classification and staging of middle ear cholesteatoma. The goals were to provide terminologies in the description of cholesteatoma, classify cholesteatoma into distinct categories to facilitate the comparison of surgical outcomes and to provide a staging system that reflects the severity, difficulty of complete removal and restoration of normal function. Cholesteatoma is considered a benign, expanding and destructive epithelial lesion of the temporal bone that is the result of a multifactorial process. If undetected and left treated, cholesteatoma may lead to significant complications including hearing loss, temporal bone destruction and cranial invasion. Recent advances in imaging modalities have allowed for high sensitivity and specificity in identifying the presence of cholesteatoma. Despite these advances, deficiencies exist around the world with access to health care facilities meaning cholesteatoma remains a serious and challenging entity to manage whether found within the pediatric or adult population. Proper diagnosis and management of each form of cholesteatoma is achieved by a thorough understanding of the etiology, classification, clinical presentation and histology, thereby facilitating prevention, early detection and appropriate treatment.

Entities:  

Keywords:  Acquired cholesteatoma; Cholesteatoma; Congenital cholesteatoma; Middle ear cholesteatoma

Mesh:

Year:  2018        PMID: 30069838      PMCID: PMC6081285          DOI: 10.1007/s12105-018-0915-5

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  55 in total

1.  Surgical treatment of middle ear cholesteatoma in children with Down syndrome.

Authors:  Andrea Bacciu; Enrico Pasanisi; Vincenzo Vincenti; Davide Giordano; Antonio Caruso; Lorenzo Lauda; Salvatore Bacciu
Journal:  Otol Neurotol       Date:  2005-09       Impact factor: 2.311

2.  Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor.

Authors:  Shinji Fukudome; Chuan Wang; Yuki Hamajima; Shengnan Ye; Yiqing Zheng; Norihiko Narita; Hiroshi Sunaga; Shigeharu Fujieda; Xiaohua Hu; Ling Feng; Jizhen Lin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-03       Impact factor: 6.223

Review 3.  Clinicopathological consultation. Ear cholesteatoma versus cholesterol granuloma.

Authors:  A Ferlito; K O Devaney; A Rinaldo; C M Milroy; B M Wenig; S Iurato; B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-01       Impact factor: 1.547

4.  Otologic disorders in Turner syndrome.

Authors:  E Bois; M Nassar; D Zenaty; J Léger; T Van Den Abbeele; N Teissier
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2017-09-21       Impact factor: 2.080

Review 5.  EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.

Authors:  Matthew Yung; Tetsuya Tono; Ewa Olszewska; Yutaka Yamamoto; Holger Sudhoff; Masafumi Sakagami; Jef Mulder; Hiromi Kojima; Armağan İncesulu; Franco Trabalzini; Nuri Özgirgin
Journal:  J Int Adv Otol       Date:  2017-01-06       Impact factor: 1.017

6.  Localization of interleukin-1 in human cholesteatoma.

Authors:  J M Ahn; C C Huang; M Abramson
Journal:  Am J Otolaryngol       Date:  1990 Mar-Apr       Impact factor: 1.808

7.  Outcomes of tympanostomy tube placement in children with Down syndrome--a retrospective review.

Authors:  Lorien M Paulson; Tyler S Weaver; Carol J Macarthur
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-11-21       Impact factor: 1.675

8.  Basal lamina breaks in the histogenesis of cholesteatoma.

Authors:  R A Chole; S P Tinling
Journal:  Laryngoscope       Date:  1985-03       Impact factor: 3.325

9.  Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases.

Authors:  Jose Evandro Andrade Prudente de Aquino; Nelson Alvares Cruz Filho; Julia Negro Prudente de Aquino
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

10.  Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.

Authors:  Mahmood A Hamed; Seiichi Nakata; Kazuya Shiogama; Kenji Suzuki; Ramadan H Sayed; Yoichi Nishimura; Noboru Iwata; Kouhei Sakurai; Badawy S Badawy; Ken-Ichi Inada; Hayato Tsuge; Yutaka Tsutsumi
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-12       Impact factor: 3.372

View more
  4 in total

1.  Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.

Authors:  Taichi Kan; Hiromi Ueda; Taishi Takahara; Yoshimasa Tsuchiya; Mayuko Kishimoto; Yasue Uchida; Tetsuya Ogawa; Wataru Ohashi; Toyonori Tsuzuki; Yasushi Fujimoto
Journal:  Biomed Res Int       Date:  2021-03-10       Impact factor: 3.411

2.  Cholesteatoma of Maxillary Sinus Simulating Neoplasia: A Rare Case Report.

Authors:  Sushma Vakalapudi; Sumit Majumdar; Divya Uppala
Journal:  Int J Appl Basic Med Res       Date:  2021-01-26

3.  Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Li Jin; Tuanfang Yin; Jihao Ren; Wei Liu
Journal:  Biomed Eng Online       Date:  2021-12-18       Impact factor: 2.819

4.  Immunohistochemical localization of d-β-aspartic acid in congenital and acquired middle ear cholesteatoma.

Authors:  Shiori Kitaya; Ryoukichi Ikeda; Jun Suzuki; Hidetoshi Oshima; Yuri Nomura; Yusuke Kusano; Nobuo Ohta; Tetsuaki Kawase; Kazue Ise; Kazuhiro Murakami; Yasuhiro Nakamura; Hironobu Sasano; Yukio Katori
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.